For every 10,000 people taking GLP-1 medications for a year, roughly 25 more would experience DVT compared to those not taking the medication
Over the past decade, few areas of medicine have captured both scientific and public attention as dramatically as GLP-1 (glucagon-like peptide-1)-based therapies
These symptoms are usually dose-related and often improve with slower dose increases, smaller meals, hydration, and avoiding overeating
While its not clear whether the drugs pose harm to human pregnancy, Ross said, widespread educational efforts are needed as a precaution. This can happen through public awareness campaigns or extra messaging in the drugs marketing materials, he added, including drug labels, ads, and packaging